Skip to search.
 TSX Up 2.88% TSX Ventures Up 2.99%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.89 Up 0.06(2.12%) Aug 27, 4:00PM EDT
Add to Portfolio
Prev Close:2.83
Open:2.85
Bid:2.60 x 5000
Ask:3.00 x 600
1y Target Est:6.50
Beta:2.24596
Earnings Date:Nov 5 - Nov 9 (Est.)
Day's Range:2.78 - 2.94
52wk Range:1.94 - 5.48
Volume:2,373,298
Avg Vol (3m):1,697,690
Market Cap:341.38M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IDRAUp 2.12%341.38M
DVAXUp 5.14%1.09B
PFEUp 2.56%205.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,708.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.46
Quarterly EPS Est (Sep-15) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback